KinoPharma, Inc. – Research and development of the new low molecule clinical drugs targeting protein kinase
- Company Name: KinoPharma, Inc.
- State/Prefecture: Tokyo Prefecture
- City/Town/Village: Chuo-Ku
- Street: 3-11-5, Nihonbashihoncho
- Country: Japan
- Zip/Postal Code: 103-0023
- Phone: +81 03-6264-9604
- Website: http://www.kinopharma.com/english/
- Listed: 09/03/2018 11:23 am
- Expires: This ad has expired
KinoPharma, Inc., located in Tokyo, is an academic biotech spin-off established in April 2005 by an entrepreneurial scientist, Professor Masatoshi Hagiwara (currently a professor at the graduate school of medicine and faculty at Kyoto University, formerly a professor at Tokyo Medical and Dental University). KinoPharma strives for R&D on novel small-molecule drugs targeting kinases involved in various viral diseases such as viral warts, epidemic keratoconjunctivitis, and hepatitis B, as well as treatment drugs for neurodegenerative diseases such as ADs. The company is headquartered in Chuo-ku Tokyo, and its CEO is Masafumi Kuroishi.
Ad Reference ID: 7975b8d8a2404cd5
Japanese Medical Research Institute and Pharmaceutical Company Collaborate to Develop New Drug for Alzheimer’s Disease
Date: Aug 29, 2018
KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by KinoPharma, to prevent the accumulation of protein called tau (hereafter “tau protein”) (*1), which is considered a cause of Alzheimer’s disease (AD). The National Institutes’ research group is led by MD & PhD Makoto Higuchi from the Department of Functional Brain Imaging Research of the National Institute of Radiological Sciences (NIRS).
Continue reading »